Direct factory supply of pharmaceutical-grade active ingredients, custom synthesis, and bulk peptide solutions.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) represents a paradigm shift in peptide therapeutics and cellular bioenergetics research. Encoded directly within the mitochondrial genome rather than nuclear DNA, this unique 16-amino acid peptide acts as a retrograde signaling molecule that regulates metabolic homeostasis, insulin sensitivity, muscle tissue adaptability, and cellular resilience against metabolic stress.
As academic research institutions, biotech startups, and clinical trial sponsors expand investigations into mitochondrial-derived peptides (MDPs), securing a scalable, highly pure, and rigorously validated supply of OEM MOTS-c 10mg lyophilized vials has become essential. This technical whitepaper evaluates the chemical synthesis roadmaps, quality control parameters, OEM production workflows, and supply chain resilience engineered by premier Chinese manufacturing entities like Gentolex.
Sequence: Met-Met-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-NH2. Sequence integrity is confirmed via high-resolution LC-MS peptide mapping.
Translocates to the nucleus upon metabolic stress, activating the AMPK (AMP-activated protein kinase) pathway and enhancing GLUT4 glucose transporter uptake.
Formulated primarily for metabolic disease models, sarcopenia research, age-related metabolic decline, and cellular endurance optimization studies.
Contract manufacturing of MOTS-c 10mg requires strict adherence to analytical parameters to guarantee batch-to-batch consistency. Below is the standard quality criteria established for high-tier OEM supply:
| Parameter | Analytical Method | Commercial OEM Standard Specification |
|---|---|---|
| Chemical Identification | Mass Spectrometry (ESI-MS / MALDI-TOF) | Monoisotopic mass fits theoretical MW (2174.65 Da ± 0.5 Da) |
| Peptide Purity | Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) | ≥ 98.0% (Research Grade) / ≥ 99.0% (Clinical/API Grade) |
| Lyophilized Appearance | Visual Inspection | White to off-white, homogeneous cake in clear glass 10mg vial |
| Bacterial Endotoxins | LAL Kinetic Chromogenic Method | < 0.1 EU/mg (Strict Low-Endotoxin Guarantee) |
| Residual Solvent Content | Headspace Gas Chromatography (HS-GC) | Acetonitrile < 410 ppm, DMF < 880 ppm, Ether < 5000 ppm |
| Counterion Content | Ion Chromatography (IC) | TFA content < 1.0% (Acetate or Salt-Free conversion available) |
| Moisture Content (KF) | Karl Fischer Titration | ≤ 5.0% w/w |
The global contract manufacturing market for mitochondrial peptides like MOTS-c, SS-31 (Elamipretide), and Humanin derivatives is experiencing an unprecedented compound annual growth rate (CAGR). Driven by an aging worldwide population and rising investment in metabolic disease therapeutics, pharmaceutical brands, clinical research organizations (CROs), and specialized peptide distributors are rapidly securing reliable supply chains.
Historically, peptide synthesis was fragmented across small-scale regional laboratories unable to meet cGMP standards at commercial scale. Today, the industry has consolidated around large-scale contract development and manufacturing organizations (CDMOs) capable of automated multi-kilogram synthesis, rapid lyophilization, and direct white-label distribution.
Enterprise buyers seeking "OEM Mots-C 10mg Suppliers" require more than simple product catalogs. Search intent highlights a strong demand for verified certificate of analysis (COA) documentation, batch stability data under ICH storage guidelines, low endotoxin thresholds, and customized vial branding options.
The demand for MOTS-c 10mg specifically stems from its dosage versatility. A 10mg single-vial configuration provides optimal volumetric balance for research reconstitution protocols, minimizing peptide degradation associated with repeated freeze-thaw cycles of larger bulk containers.
Synthesizing a 16-amino acid peptide with multiple hydrophobic residues (such as Methionine, Tryptophan, and Tyrosine) presents specific chemical bottlenecks, including hydrophobic aggregation during chain assembly and oxidation-sensitive methionine residues.
Utilizing Microwave-Assisted Fmoc/tBu SPPS protocol on high-capacity Rink Amide resin to maximize coupling yield (>99.2% per amino acid addition step) while preventing racemate formation.
Methionine residues at positions 1, 2, and 6 are protected against premature sulfoxide oxidation using specialized nitrogen-blanketed cleavage cocktails and scavenger mixtures (EDT/TIS/H2O/TFA).
Dual-stage purification utilizing C18 dynamic axial compression (DAC) columns. Stage 1 removes deletion peptides; Stage 2 exchanges Trifluoroacetate (TFA) counterions to bio-friendly Acetate or Hydrochloride salts.
While lyophilized injection vials remain the gold standard for clinical purity, future OEM development centers on advanced drug delivery systems (DDS):
The industrial and academic application of MOTS-c 10mg spans several distinct sectors globally. Contract manufacturers must cater to localized regulatory requirements and technical specifications depending on the end-use environment.
In North American and Western European bioclusters, MOTS-c 10mg vials are utilized in preclinical research investigating insulin resistance reversed via skeletal muscle glucose clearance. High-purity, endotoxin-controlled preparations are critical to avoid false-positive cytokine responses in cell culture models.
Research centers in Asia-Pacific and Latin America focus on age-related muscle loss (sarcopenia). MOTS-c acts as an exercise mimetic by stimulating cellular bioenergetics; thus, OEM suppliers must provide consistent batch uniformity for long-term dosage studies.
Biotech firms operating in longevity hubs (e.g., Switzerland, Singapore, USA) evaluate MOTS-c in combination with NAD+ boosters and mitochondrial targeted antioxidants (like SS-31) to evaluate synergistic anti-aging markers.
Specialty chemical brands engage OEM partners to deliver turn-key finished products: custom vial flip-off caps (with brand logo engraving), custom colored flip tops, vacuum-sealed sterile packaging, and localized multi-language compliance labeling.
China has established itself as the global epicenter for peptide raw material synthesis and contract active pharmaceutical ingredient (API) manufacturing. Through heavy capital investment in automated industrial facilities, advanced environmental controls, and vertical raw material integration, Chinese manufacturers offer unparalleled value for international B2B clients.
As detailed in our corporate baseline, Gentolex operates state-of-the-art facilities engineered to meet international cGMP, ISO 9001, and ISO 13485 quality management systems:
An overall factory construction area built under international standards to offer scalable, highly flexible, and cost-effective bulk synthesis from grams to multi-kilograms.
In-house production of protected amino acids (Fmoc/Boc derivatives, disulfide bond reagents) guarantees zero raw material shortages and eliminates supply bottlenecks.
Comprehensive Finished Dosage Form (FDF) license-out capabilities, lab setup consultation, technical support, and complete regulatory documentation support.
Through robust cold-chain supply chain protocols, Gentolex ensures safe, temperature-controlled delivery (2-8°C or -20°C dry-ice logistics) to international partners across North America, Europe, Latin America, and Africa.
Ensuring compliance with global health authorities (FDA, EMA, NMPA) requires exhaustive documentation and local support channels. Gentolex has established localized support networks with regional representatives in key hubs, including Mexico and South Africa, facilitating real-time technical consultation and regulatory assistance.
Every step of the OEM MOTS-c 10mg production process is governed by strictly audited Standard Operating Procedures (SOPs). Cleanroom environmental monitoring (Class 100 / ISO 5 areas) prevents microbial contamination during vial filling and lyophilization stages.
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), developed through advanced neuropharmacological research...
View Details
As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and scientific organizations...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention due to its bioactivity related to tissue repair, gastrointestinal protection, and inflammatory regulation...
View Details
With continuous developments in peptide chemistry, neuroactive peptides have become a key scientific area. Semax, an ACTH fragment derivative, delivers remarkable neuro-research capabilities...
View Details
SS-31 API, also known as Elamipretide or MTP-131, is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, stabilizing bioenergetics...
View Details
Direct answers to common technical, procurement, and regulatory queries regarding OEM MOTS-c 10mg manufacturing.
Our standard OEM lyophilization batch MOQs start at 100 vials for white-label research packaging, and scale up to 10,000+ vials for commercial distribution contracts. Custom vial caps, custom labeling, and custom box packaging options are available across all volume tiers.
Every single OEM batch undergoes rigorous analytical testing: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) confirms purity ≥98% or ≥99%, and Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) / Electrospray Ionization Mass Spectrometry (ESI-MS) verifies correct molecular weight. Full raw data graphs are provided in the certificate of analysis.
Standard crude synthesis leaves Trifluoroacetate (TFA) counterions. For cell culture assays or sensitive biological studies, we perform automated ion exchange chromatography to yield Acetate (AcO-) salts or salt-free formulations, keeping TFA levels below 1.0% or non-detectable.
Lyophilized MOTS-c 10mg cakes remain stable at ambient temperature during express international transport for up to 2-3 weeks. However, upon arrival, long-term storage is recommended at -20°C in a desiccated environment. Reconstituted peptide solutions should be aliquoted and kept at -80°C to prevent degradation.
Yes. Gentolex specializes in FDF license-out agreements, offering comprehensive technical dossier support, master batch records (MBR), stability study protocol alignment, and complete facility setup consultations for international clients.
Explore our full commercial inventory of protected amino acids, therapeutic APIs, and specialty research reagents.
